Ducommun Swings to Q3 Loss on $99.7M Litigation Hit, Revenue Up 5.5%

TL;DR

**DCO got hammered by a $99.7M litigation charge, making Q3 a total bust despite decent revenue growth; stay cautious until the dust settles.**

AI Summary

Ducommun Inc. reported a significant net loss of $64.446 million for the three months ended September 27, 2025, a stark contrast to the net income of $10.148 million in the prior-year period. This substantial loss was primarily driven by $99.675 million in litigation settlement and related costs. Despite the net loss, the company saw a revenue increase of 5.5% to $212.558 million for the quarter, up from $201.412 million in the same period last year. For the nine months ended September 27, 2025, Ducommun recorded a net loss of $41.382 million, compared to a net income of $24.721 million in the corresponding nine-month period of 2024. Cash and cash equivalents increased to $50.918 million as of September 27, 2025, from $37.139 million at December 31, 2024, largely due to $41.282 million in net cash provided by operating activities. Total assets grew to $1.248 billion from $1.126 billion, while total liabilities increased to $599.525 million from $443.571 million, reflecting the impact of accrued liabilities related to the litigation settlement. The company's strategic outlook continues to focus on its Electronic Systems and Structural Systems segments, serving the aerospace and defense, industrial, and medical industries.

Why It Matters

Ducommun's substantial net loss due to a nearly $100 million litigation settlement is a critical event for investors, significantly impacting profitability and shareholder equity. While revenue growth of 5.5% suggests underlying business strength in its aerospace and defense segments, the one-time charge overshadows operational performance. This settlement could free up management to focus on core business, but the financial hit may limit future investments or shareholder returns. Competitors might see this as a moment to gain market share if Ducommun's financial flexibility is constrained, potentially affecting employees and customers through delayed innovation or reduced capacity.

Risk Assessment

Risk Level: high — The company reported a net loss of $64.446 million for the three months ended September 27, 2025, primarily due to $99.675 million in litigation settlement and related costs. This significant, non-recurring expense represents a substantial financial hit, impacting retained earnings which decreased from $453.475 million at December 31, 2024, to $412.093 million at September 27, 2025, and increasing accrued and other liabilities to $194.227 million from $44.214 million.

Analyst Insight

Investors should closely monitor Ducommun's subsequent filings for details on how the company plans to mitigate the financial impact of the $99.675 million litigation settlement. While the revenue growth is positive, the significant one-time charge warrants a cautious approach; consider holding or reducing exposure until a clear path to sustained profitability post-settlement is demonstrated.

Financial Highlights

debt To Equity

0.92

revenue

$212.558M

operating Margin

-37.7%

total Assets

$1.248B

total Debt

$227.546M

net Income

$ -64.446M

eps

N/A

gross Margin

26.6%

cash Position

$50.918M

revenue Growth

+5.5%

Revenue Breakdown

Key Numbers

• $64.446M — Net Loss (For the three months ended September 27, 2025, compared to $10.148M net income in prior year.)
• $99.675M — Litigation Settlement and Related Costs (Primary driver of the net loss for the three and nine months ended September 27, 2025.)
• $212.558M — Net Revenues (For the three months ended September 27, 2025, up from $201.412M in prior year.)
• $41.382M — Net Loss (For the nine months ended September 27, 2025, compared to $24.721M net income in prior year.)
• $50.918M — Cash and Cash Equivalents (As of September 27, 2025, up from $37.139M at December 31, 2024.)
• $41.282M — Net Cash Provided by Operating Activities (For the nine months ended September 27, 2025, up from $15.756M in prior year.)
• $1.248B — Total Assets (As of September 27, 2025, up from $1.126B at December 31, 2024.)
• $599.525M — Total Liabilities (As of September 27, 2025, up from $443.571M at December 31, 2024.)
• $194.227M — Accrued and Other Liabilities (As of September 27, 2025, significantly increased from $44.214M at December 31, 2024, due to litigation.)
• 14,946,052 — Common Stock Outstanding (As of October 28, 2025.)

Key Players & Entities

• DUCOMMUN INC /DE/ (company) — Registrant
• DCO (company) — Ticker symbol
• New York Stock Exchange (regulator) — Exchange where DCO is registered
• U.S. government (regulator) — Defense spending dependency
• Defense Contract Audit Agency (regulator) — Regulatory body for operations
• Guaymas, Mexico (company) — Location of production facility
• Electronic Systems (company) — Reportable operating segment
• Structural Systems (company) — Reportable operating segment
• Bloomberg (company) — Publisher of analysis
• SEC (regulator) — Filing oversight

FAQ

Risk Factors

• Significant Litigation Impact [high — legal]: The company incurred a $99.675 million charge for litigation settlement and related costs in the three and nine months ended September 27, 2025. This resulted in a net loss of $64.446 million for the quarter and $41.382 million for the nine months, significantly impacting profitability and balance sheet with a surge in accrued liabilities to $194.227 million.
• Increased Leverage and Debt Service [medium — financial]: Total liabilities increased to $599.525 million from $443.571 million, driven by accrued litigation costs. While cash increased to $50.918 million, the substantial increase in liabilities and the need to service existing debt, as mentioned in forward-looking statements, pose a financial risk.
• Inventory Management Challenges [medium — operational]: Inventories decreased slightly to $192.817 million from $196.881 million. However, the company's ability to manage inventory effectively, especially with fluctuating demand in aerospace and defense, remains a key operational consideration.
• Aerospace and Defense Market Volatility [medium — market]: The company's primary markets in aerospace and defense are subject to cyclicality and government spending fluctuations. While demand in commercial aerospace is noted as a driver, potential shifts in defense budgets or program delays could impact future revenues.
• Integration of Acquisitions [medium — operational]: The company's strategy includes future acquisitions. The successful integration of acquired businesses and realization of expected synergies are critical for long-term value creation and can present operational challenges.
• Dependence on Credit Facilities [medium — financial]: Forward-looking statements mention covenants in credit facilities and the company's level of indebtedness. Adherence to these covenants and the ability to service debt are crucial for financial stability.

Industry Context

Ducommun Inc. operates in the aerospace and defense, industrial, and medical industries, serving a market characterized by long production cycles and significant R&D investment. The aerospace and defense sector, a key focus, is influenced by government defense spending, commercial aircraft production rates, and supply chain dynamics. Competitors range from large diversified manufacturers to specialized component suppliers.

Regulatory Implications

The company is subject to various regulations within the aerospace and defense sector, including compliance with government contracts and quality standards. While no specific new regulatory issues are highlighted, ongoing adherence to these standards is critical. The significant litigation settlement could also draw scrutiny regarding corporate governance and risk management practices.

What Investors Should Do

1. Monitor litigation impact resolution
2. Analyze operating segment performance
3. Assess cash flow generation and liquidity
4. Evaluate debt levels and covenants

Key Dates

• 2025-09-27: Quarter End — Reported significant net loss of $64.446M due to litigation settlement, despite revenue growth.
• 2025-09-27: Balance Sheet Date — Total assets grew to $1.248B, but total liabilities surged to $599.525M, largely due to accrued litigation costs.
• 2025-09-27: Nine Months End — Net loss of $41.382M recorded, contrasting with prior year's net income, primarily due to litigation.
• 2024-12-31: Prior Year End — Provided a baseline for comparison of asset and liability growth, with total liabilities at $443.571M.

Glossary

Accrued and other liabilities

Obligations that have been incurred but not yet paid. This includes expenses like salaries, rent, and taxes, as well as provisions for potential future costs such as litigation settlements. (Significantly increased to $194.227M from $44.214M, directly reflecting the impact of the litigation settlement and related costs.)

Contract assets

Represents the company's right to consideration in exchange for goods or services that the company has transferred to a customer. It arises when the company has performed its obligations but has not yet billed the customer. (Increased to $248.402M from $200.584M, indicating a growing backlog of unbilled work, potentially related to increased revenue.)

Operating (Loss) Income

Profit or loss from a company's core business operations before accounting for interest expenses, taxes, and other non-operating income or expenses. (Turned negative to a loss of $80.050M for the quarter, primarily due to the large litigation settlement, compared to a positive income of $15.266M in the prior year.)

Litigation Settlement and Related Costs, Net

The expenses incurred by the company to resolve legal disputes, including settlement amounts, legal fees, and other associated costs. (A significant $99.675M charge for the period, directly causing the substantial net loss reported.)

Net Cash Provided by Operating Activities

The net amount of cash generated from a company's normal business operations over a period. (Increased to $41.282M for the nine months, a positive sign for cash generation from core operations, despite the overall net loss.)

Year-Over-Year Comparison

Compared to the prior year, Ducommun Inc. experienced a dramatic shift from net income to a significant net loss of $64.446 million for the three months ended September 27, 2025, primarily due to a $99.675 million litigation settlement. While net revenues saw a healthy increase of 5.5% to $212.558 million, the substantial one-time charge overshadowed this growth. Total assets grew to $1.248 billion, but total liabilities also surged to $599.525 million, a marked increase from $443.571 million at the end of the prior year, reflecting the impact of accrued liabilities related to the litigation. Operating cash flow for the nine months improved significantly to $41.282 million, a positive indicator amidst the reported losses.

Filing Documents

• dco-20250927.htm (10-Q) — 1415KB
• dcoq3202510-qex31_1.htm (EX-31.1) — 10KB
• dcoq3202510-qxex31_2.htm (EX-31.2) — 10KB
• dcoq3202510-qxex32.htm (EX-32) — 9KB
• 0001628280-25-049803.txt ( ) — 6797KB
• dco-20250927.xsd (EX-101.SCH) — 39KB
• dco-20250927_cal.xml (EX-101.CAL) — 57KB
• dco-20250927_def.xml (EX-101.DEF) — 215KB
• dco-20250927_lab.xml (EX-101.LAB) — 541KB
• dco-20250927_pre.xml (EX-101.PRE) — 384KB
• dco-20250927_htm.xml (XML) — 984KB

. FINANCIAL INFORMATION

PART I . FINANCIAL INFORMATION

Forward Looking Statements

Forward Looking Statements 3

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) 5 Condensed Consolidated Balance Sheets as of September 27, 2025 and December 31, 2024 5 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 27, 2025 and September 28, 2024 6 Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three and Nine Months Ended September 27, 2025 and September 28, 2024 7 Condensed Consolidated Statements of Changes in Shareholders' Equity for the Three and Nine Months Ended September 27, 2025 and September 28, 2024 8 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 27, 2025 and September 28, 2024 9 Notes to Condensed Consolidated Financial Statements 10

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 26

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 40

Controls and Procedures

Item 4. Controls and Procedures 41

. OTHER INFORMATION

PART II . OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 42

Risk Factors

Item 1A. Risk Factors 42

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 42

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 42

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 42

Other Information

Item 5. Other Information 42

Exhibits

Item 6. Exhibits 43

Signatures

Signatures 44 2 Table of Contents

FORWARD-LOOKING STATEMENTS AND RISK FACTORS

FORWARD-LOOKING STATEMENTS AND RISK FACTORS This Quarterly Report on Form 10-Q ("Form 10-Q") contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be preceded by, followed by or include words such as "could," "may," "believe," "expect," "anticipate," "plan," "estimate," "expect," "would," or similar expressions. These statements are based on the beliefs and assumptions of our management at the time such statements are made. Generally, forward-looking statements include information concerning our possible or assumed future actions, events or results of operations. Forward-looking statements specifically include, without limitation, the information in this Form 10-Q regarding: future sales, earnings, cash flow, revenue recognition, uses of cash and other measures of financial performance, projections or expectations for future operations, including costs to complete contracts, goodwill impairment evaluations, useful life of intangible assets, unrecognized tax benefits and effective tax rate, possible labor disruptions, environmental remediation costs, insurance recoveries, industry trends and expectations, including ramp up times for build rates, our plans with respect to restructuring activities, capital expenditures, completed acquisitions, future acquisitions and dispositions and expected business opportunities that may be available to us. Although we believe that the expectations reflected in the forward-looking statements are based on reasonable assumptions, these forward-looking statements are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. We cannot guarantee future results, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. All written and oral forward-looking sta

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Ducommun Incorporated and Subsidiaries Condensed Consolidated Balance Sheets (Unaudited) (Dollars in thousands, except share and per share data) September 27, 2025 December 31, 2024 Assets Current Assets Cash and cash equivalents $ 50,918 $ 37,139 Accounts receivable, net of allowance for credit losses of $ 2,039 and $ 2,630 at September 27, 2025 and December 31, 2024, respectively 111,269 109,716 Contract assets 248,402 200,584 Inventories 192,817 196,881 Production cost of contracts 5,685 6,802 Other current assets 72,259 16,959 Total Current Assets 681,350 568,081 Property and Equipment, Net of Accumulated Depreciation of $ 202,781 and $ 194,921 at September 27, 2025 and December 31, 2024, respectively 107,361 109,812 Operating Lease Right-of-Use Assets 42,173 28,611 Goodwill 244,600 244,600 Intangibles, Net 137,027 149,591 Deferred Income Taxes 18,172 2,239 Other Assets 17,887 23,167 Total Assets $ 1,248,570 $ 1,126,101 Liabilities and Shareholders' Equity Current Liabilities Accounts payable $ 85,281 $ 75,784 Contract liabilities 34,450 34,445 Accrued and other liabilities 194,227 44,214 Operating lease liabilities 7,796 8,531 Current portion of long-term debt 12,500 12,500 Total Current Liabilities 334,254 175,474 Long-Term Debt, Less Current Portion 215,046 229,830 Non-Current Operating Lease Liabilities 36,129 21,284 Other Long-Term Liabilities 14,096 16,983 Total Liabilities 599,525 443,571 Commitments and Contingencies (Notes 8, 10) Shareholders' Equity Common Stock - $ 0.01 par value; 35,000,000 shares authorized; 14,945,835 and 14,781,218 shares issued and outstanding at September 27, 2025 and December 31, 2024, respectively 149 148 Additional Paid-In Capital 229,980 217,523 Retained Earnings 412,093 453,475 Accumulated Other Comprehensive Income 6,823 11,384 Total Shareholders' Equity 649,045 682,530 Total Liabilities and Shareholders' Equity $ 1,248,570 $ 1,126,101 See acc

View Full Filing

View this 10-Q filing on SEC EDGAR